Veterinary Anti-infectives Market– By Animal Type, By Product Type, By Route of Administration, By Distribution Channel, Global Forecast, 2024 – 2032

Veterinary Anti-infectives Market Size

The veterinary anti-infectives market size was valued at USD 5.4 billion in 2023 and is estimated to grow at 3.5% CAGR from 2024 to 2032. The veterinary anti-infective market has grown significantly, largely due to the increasing incidence of infectious diseases in livestock and companion animals.
 

The intensification of livestock farming, driven by rising global demand for meat and animal-based products, has heightened the risk of infections stemming from close living conditions. For instance, according to the World Health Organization (WHO), there are over 200 recognized zoonotic diseases, including bacterial, viral, and parasitic infections. Notably, 60% of infectious diseases are zoonotic in origin, and 75% of emerging human pathogens stem from animals. This trend drives the demand for anti-infectives, which are essential in controlling and preventing zoonotic outbreaks, prompting increased investment from governments, farmers, and pet owners.
 

Anti-infectives are crucial for controlling bacterial, viral, and fungal infections, preventing disease outbreaks that could lead to substantial economic losses in agriculture, and ensuring animal welfare within the companion animal sector. These treatments play a vital role in maintaining animal health across various species and settings. Additionally, the rise in pet ownership has intensified the focus on animal healthcare, further boosting the demand for effective treatments.
 

Veterinary anti-infectives are pharmaceutical agents used to prevent, treat, and control infections caused by bacteria, viruses, fungi, and parasites in animals, including livestock and companion animals. These products are essential for maintaining animal health and reducing the spread of zoonotic diseases that can be transmitted to humans. The veterinary anti-infectives market includes various types of drugs, such as antibiotics, antivirals, antifungals, and antiparasitics, which are widely used in both preventive care and the treatment of infectious diseases in veterinary medicine.
 

Veterinary Anti-infectives Market Trends

The rising demand for meat and animal products has significantly increased the need for veterinary anti-infectives in the market. As livestock farming intensifies to meet consumer needs, animals become more susceptible to infections, necessitating effective treatments to maintain their health. Veterinary anti-infectives are crucial for preventing and managing diseases in livestock, ensuring food safety, and reducing the risk of zoonotic diseases that can impact public health. This trend drives market growth.
 

• For instance, the U.S., a leading beef producer, is currently facing a significant challenge with an outbreak of bird flu among cattle. According to May 2024 reports from the U.S. FDA, over 250 beef products from more than 38 states have tested positive for high-pathogenic avian influenza (HPAI). This situation poses a critical obstacle to beef production but also presents an opportunity for industry players to develop effective therapies to address the outbreak.
   
• Similarly, South Africa heavily relies on poultry production and has been severely impacted by HPAI, resulting in a substantial 30% decline in egg production and the culling of over a million poultry, as reported by Poultry World in December 2023. These occurrences highlight the urgent need for effective therapies to prevent disease outbreaks in both companion and farmed animals, fostering potential market growth opportunities.
   

Veterinary Anti-infectives Market Analysis

Based on the animal type, the market is categorized as livestock animals and companion animals. The livestock animals segment is set to lead the market, accounting for the largest revenue in 2023, anticipating its dominance throughout the forecast period with a CAGR of 3.4%. The livestock animals segment is further categorized into poultry, swine, cattle, and other livestock animals.
 

• The prominence of livestock animals in the market is attributed to the increasing need for disease prevention and management in large-scale animal farming.
   
• Factors such as rising global meat consumption, growing awareness of animal health, and the need to maintain productivity and profitability in livestock operations drive the demand for anti-infective medications.
   
• Additionally, regulations requiring the use of veterinary products to ensure food safety and quality further enhance this segment's prominence.
   
• Furthermore, the prevalence of infectious diseases among livestock, coupled with advancements in veterinary medicine, continues to support the growth of anti-infectives tailored for farm animals, leading to a significant market share.

Based on product type, the veterinary anti-infectives market is classified into antibacterial, antifungal, antivirals, and antiparasitics. The antibacterial segment holds the largest market share of 44.3% in 2023 and is expected to maintain dominance throughout the analysis period.
 

• The antibacterial segment dominates the market, primarily due to its essential role in treating bacterial infections in animals.
   
• The increasing prevalence of bacterial diseases among livestock and companion animals drives the demand for effective antibacterial agents.
   
• Additionally, the growing concern over antibiotic resistance underscores the need for continuous research and development in antibacterial treatments.
   
• Furthermore, regulatory frameworks that promote judicious antibiotic use also contribute to this segment's growth, as veterinarians seek effective solutions to manage infections while minimizing the risks of resistance.
   
• Therefore, the emphasis on animal health and welfare further reinforces the importance of antibacterial treatments in veterinary medicine.
   

Based on the route of administration, the veterinary anti-infectives market is segmented into oral, parenteral, topical, and other routes of administration. The oral segment dominated the market with a market revenue of USD 2.2 billion in 2023.
 

• The dominance of the oral segment stems from its ease of administration and effectiveness in treating various infections in animals.
   
• Oral formulations, such as tablets, powders, and suspensions, are preferred for their convenience, allowing pet owners and farmers to administer medication without specialized training. This accessibility increases compliance and ensures timely treatment of infections.
   
• Additionally, oral anti-infectives are often more cost-effective compared to injectable alternatives, further enhancing their market share.
   

Based on the distribution channel, the veterinary anti-infectives market is segmented into retail pharmacies, online pharmacies, and veterinary hospital pharmacies. The retail pharmacies segment dominated the market with the highest share in 2023.
 

• The dominance of the retail pharmacies segment is attributed to their widespread accessibility and convenience for pet owners.
   
• Retail pharmacies provide a range of veterinary medications, including anti-infectives, making it easy for customers to obtain necessary treatments without the need for specialized veterinary clinics.
   
• Furthermore, the increasing pet ownership and rising awareness of animal health have further fuelled demand for veterinary products in these outlets.
   
• Additionally, retail pharmacies often offer competitive pricing and promotions, attracting more consumers.
   
• Thus, the convenience of immediate access to medications for routine animal care and emergencies solidifies the retail pharmacy segment's leading position in the market.

The U.S. veterinary anti-infectives market accounted for USD 2 billion in 2023 and is anticipated to show considerable growth over the analysis period.
 

• The prominence of the U.S. in the market is driven by advanced healthcare infrastructure, substantial research and development investments, and a high prevalence of infectious diseases in both human and veterinary populations.
   
• The country’s stringent regulatory environment ensures the safety and efficacy of anti-infective products, fostering innovation among pharmaceutical companies.
   
• Moreover, increasing pet ownership and the demand for livestock products contribute to the rising need for veterinary anti-infectives, further bolstering the market.
   
• Furthermore, the U.S. benefits from a strong distribution network, enabling quick access to various anti-infective medications.
   
• Additionally, growing awareness of antibiotic resistance has prompted initiatives to promote responsible usage, thereby enhancing the market's focus on developing novel anti-infective solutions.
   
• Thus, the aforementioned factors underscore the U.S.'s leadership in the North American anti-infectives market.
   

Germany exhibits a high growth potential in the European veterinary anti-infectives market.
 

• Germany stands out in this market due to its strong animal healthcare infrastructure, stringent animal welfare regulations, and high rates of pet ownership. The country's commitment to maintaining high standards for animal care significantly drives the demand for effective anti-infective treatments.
   
• Moreover, leading companies in the market are responding to the increasing trend of pet humanization by establishing manufacturing and R&D facilities in Germany. This strategic move enables them to develop and provide targeted anti-infective products that meet the growing expectations of pet owners for advanced veterinary care.
   
• Thus, these factors position Germany as a key player in the market.
   

China held a prominent position in Asia veterinary anti-infectives market anticipating dominance throughout during the forecast period.
 

• China's leadership is driven by its large livestock population and increasing investments in animal health and veterinary services.
   
• Growing awareness of animal welfare, coupled with stringent regulations on antibiotic use, has led to heightened demand for effective anti-infective treatments.
   
• Additionally, advancements in veterinary medicine and technology are facilitating the development of new formulations and therapies.
   
• As China prioritizes food safety and livestock productivity, its prominence in the market is expected to expand further.
   

Saudi Arabia is poised to grow at a significant growth rate in the Middle East and African veterinary anti-infectives market.
 

• The projected growth in Saudi Arabia is driven by increasing investments in animal healthcare and a growing awareness of the importance of disease prevention in livestock.
   
• The rise in livestock farming, coupled with the government's focus on food security and quality assurance, is boosting the demand for effective anti-infective treatments.
   
• Additionally, advancements in veterinary medicine and stricter regulations on antibiotic use are encouraging the adoption of innovative solutions.
   
• As the country prioritizes animal health and welfare, its market for veterinary anti-infectives is expected to expand significantly.
   

Veterinary Anti-infectives Market Share

The market is characterized by the presence of several key players, including multinational pharmaceutical companies and specialized veterinary companies. Major companies focus on research and development to innovate and expand their product offerings, targeting both livestock and companion animals. Furthermore, strategic collaborations, mergers, and acquisitions are common as firms seek to enhance their market presence and diversify their portfolios. Additionally, companies are increasingly emphasizing sustainable practices and responsible antibiotic use to address rising concerns about antibiotic resistance, further shaping the competitive dynamics within the market.
 

Veterinary Anti-infectives Market Companies

Few of the prominent players operating in the veterinary anti-infectives industry include:

• Aspen Veterinary Resources
• Boehringer Ingelheim International
• Ceva 
• Dechra Pharmaceuticals
• Elanco 
• Merck & Co
• Norbrook 
• Phibro Animal Health
• Vetoquinol S.A.
• Virbac
• Zoetis
   

Veterinary Anti-infectives Industry News:

• In February 2024, Blacksmith Medicines, Inc. partnered with Zoetis to collaborate on the discovery and development of innovative antibiotics for animal health. This partnership aimed to enhance the effectiveness of treatments available for animals, addressing the growing need for novel solutions in veterinary medicine.
   
• In January 2023, Norbrook expanded its extensive antibiotic lineup with the introduction of Tulieve, a tulathromycin injection. This new generic injectable is available in an exclusive plastic bottle and comes in four different sizes. Tulieve is now part of Norbrook's comprehensive portfolio of anti-infective products designed for veterinarians treating food animals. This addition underscored Norbrook's commitment to providing effective solutions for animal health, enhancing the options available for veterinarians in managing infections in livestock.
   

The veterinary anti-infectives market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Animal Type

• Livestock animals
  • Cattle
  • Poultry
  • Swine
  • Other livestock animals 
• Companion animals
  • Dogs
  • Cats
  • Other companion animals

Market, By Product Type

• Antibacterial
• Antifungal
• Antivirals
• Antiparasitics

Market, By Route of Administration

• Oral
• Parenteral
• Topical
• Other routes of administration

Market, By Distribution Channel

• Retail pharmacies
• Online pharmacies
• Veterinary hospital pharmacies

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE